nodes	percent_of_prediction	percent_of_DWPC	metapath
Nelarabine—DGUOK—eye—melanoma	0.0117	0.14	CbGeAlD
Nelarabine—DGUOK—retina—melanoma	0.0116	0.139	CbGeAlD
Nelarabine—DGUOK—mammalian vulva—melanoma	0.00928	0.111	CbGeAlD
Nelarabine—Adenosine triphosphate—APAF1—melanoma	0.0077	0.758	CrCbGaD
Nelarabine—POLA1—retina—melanoma	0.00715	0.0855	CbGeAlD
Nelarabine—DGUOK—head—melanoma	0.00664	0.0794	CbGeAlD
Nelarabine—POLA1—mammalian vulva—melanoma	0.00572	0.0685	CbGeAlD
Nelarabine—ADA—mammalian vulva—melanoma	0.00531	0.0635	CbGeAlD
Nelarabine—DGUOK—lymph node—melanoma	0.00465	0.0556	CbGeAlD
Nelarabine—DCK—retina—melanoma	0.00441	0.0527	CbGeAlD
Nelarabine—ADA—head—melanoma	0.0038	0.0454	CbGeAlD
Nelarabine—DCK—mammalian vulva—melanoma	0.00353	0.0422	CbGeAlD
Nelarabine—POLA1—lymph node—melanoma	0.00287	0.0343	CbGeAlD
Nelarabine—ADA—lymph node—melanoma	0.00266	0.0318	CbGeAlD
Nelarabine—DCK—head—melanoma	0.00252	0.0302	CbGeAlD
Nelarabine—Adenosine triphosphate—AKT1—melanoma	0.00209	0.206	CrCbGaD
Nelarabine—Lethargy—Dactinomycin—melanoma	0.00197	0.00331	CcSEcCtD
Nelarabine—Rigors—Docetaxel—melanoma	0.00196	0.0033	CcSEcCtD
Nelarabine—Amnesia—Carmustine—melanoma	0.00192	0.00323	CcSEcCtD
Nelarabine—Amnesia—Temozolomide—melanoma	0.00185	0.00313	CcSEcCtD
Nelarabine—Cough—Vemurafenib—melanoma	0.00179	0.00302	CcSEcCtD
Nelarabine—DCK—lymph node—melanoma	0.00177	0.0212	CbGeAlD
Nelarabine—Hyperbilirubinaemia—Docetaxel—melanoma	0.00176	0.00296	CcSEcCtD
Nelarabine—Myalgia—Vemurafenib—melanoma	0.00175	0.00295	CcSEcCtD
Nelarabine—Arthralgia—Vemurafenib—melanoma	0.00175	0.00295	CcSEcCtD
Nelarabine—Aspartate aminotransferase increased—Dactinomycin—melanoma	0.00173	0.00292	CcSEcCtD
Nelarabine—Ataxia—Carmustine—melanoma	0.0017	0.00286	CcSEcCtD
Nelarabine—Blood bilirubin increased—Docetaxel—melanoma	0.00169	0.00284	CcSEcCtD
Nelarabine—Infection—Vemurafenib—melanoma	0.00166	0.00281	CcSEcCtD
Nelarabine—Nervous system disorder—Vemurafenib—melanoma	0.00164	0.00277	CcSEcCtD
Nelarabine—Hypokalaemia—Carmustine—melanoma	0.00164	0.00277	CcSEcCtD
Nelarabine—Ataxia—Temozolomide—melanoma	0.00164	0.00276	CcSEcCtD
Nelarabine—Dehydration—Temozolomide—melanoma	0.00162	0.00273	CcSEcCtD
Nelarabine—Pneumonia—Bleomycin—melanoma	0.0016	0.0027	CcSEcCtD
Nelarabine—Muscular weakness—Carmustine—melanoma	0.00159	0.00268	CcSEcCtD
Nelarabine—Hypokalaemia—Temozolomide—melanoma	0.00159	0.00267	CcSEcCtD
Nelarabine—Aspartate aminotransferase increased—Temozolomide—melanoma	0.00157	0.00264	CcSEcCtD
Nelarabine—Hypotension—Vemurafenib—melanoma	0.00157	0.00264	CcSEcCtD
Nelarabine—Neutropenia—Dactinomycin—melanoma	0.00156	0.00262	CcSEcCtD
Nelarabine—Stomatitis—Bleomycin—melanoma	0.00155	0.00262	CcSEcCtD
Nelarabine—Muscular weakness—Temozolomide—melanoma	0.00154	0.00259	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Vemurafenib—melanoma	0.00153	0.00257	CcSEcCtD
Nelarabine—Abdominal distension—Temozolomide—melanoma	0.00152	0.00256	CcSEcCtD
Nelarabine—Neuropathy—Docetaxel—melanoma	0.0015	0.00253	CcSEcCtD
Nelarabine—Pneumonia—Dactinomycin—melanoma	0.00149	0.00252	CcSEcCtD
Nelarabine—Neutropenia—Carmustine—melanoma	0.00146	0.00246	CcSEcCtD
Nelarabine—Decreased appetite—Vemurafenib—melanoma	0.00146	0.00246	CcSEcCtD
Nelarabine—Stomatitis—Dactinomycin—melanoma	0.00145	0.00244	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Vemurafenib—melanoma	0.00145	0.00244	CcSEcCtD
Nelarabine—Fatigue—Vemurafenib—melanoma	0.00144	0.00244	CcSEcCtD
Nelarabine—Neoplasm—Docetaxel—melanoma	0.00144	0.00243	CcSEcCtD
Nelarabine—Constipation—Vemurafenib—melanoma	0.00143	0.00242	CcSEcCtD
Nelarabine—Hypoaesthesia—Bleomycin—melanoma	0.00142	0.0024	CcSEcCtD
Nelarabine—Neutropenia—Temozolomide—melanoma	0.00141	0.00237	CcSEcCtD
Nelarabine—Hyperglycaemia—Carmustine—melanoma	0.00141	0.00237	CcSEcCtD
Nelarabine—Pneumonia—Carmustine—melanoma	0.0014	0.00236	CcSEcCtD
Nelarabine—Depression—Carmustine—melanoma	0.00139	0.00234	CcSEcCtD
Nelarabine—Sepsis—Docetaxel—melanoma	0.00139	0.00233	CcSEcCtD
Nelarabine—Neuropathy peripheral—Carmustine—melanoma	0.00136	0.0023	CcSEcCtD
Nelarabine—Hyperglycaemia—Temozolomide—melanoma	0.00136	0.00229	CcSEcCtD
Nelarabine—Stomatitis—Carmustine—melanoma	0.00135	0.00228	CcSEcCtD
Nelarabine—Pneumonia—Temozolomide—melanoma	0.00135	0.00228	CcSEcCtD
Nelarabine—Infestation—Temozolomide—melanoma	0.00134	0.00226	CcSEcCtD
Nelarabine—Infestation NOS—Temozolomide—melanoma	0.00134	0.00226	CcSEcCtD
Nelarabine—Depression—Temozolomide—melanoma	0.00134	0.00226	CcSEcCtD
Nelarabine—Body temperature increased—Vemurafenib—melanoma	0.00132	0.00223	CcSEcCtD
Nelarabine—Neuropathy peripheral—Temozolomide—melanoma	0.00132	0.00222	CcSEcCtD
Nelarabine—Stomatitis—Temozolomide—melanoma	0.00131	0.00221	CcSEcCtD
Nelarabine—Chills—Bleomycin—melanoma	0.00128	0.00216	CcSEcCtD
Nelarabine—Hepatobiliary disease—Temozolomide—melanoma	0.00127	0.00214	CcSEcCtD
Nelarabine—Sinusitis—Temozolomide—melanoma	0.00126	0.00212	CcSEcCtD
Nelarabine—Hypoaesthesia—Carmustine—melanoma	0.00124	0.00209	CcSEcCtD
Nelarabine—Oedema peripheral—Carmustine—melanoma	0.00123	0.00207	CcSEcCtD
Nelarabine—Connective tissue disorder—Carmustine—melanoma	0.00123	0.00207	CcSEcCtD
Nelarabine—Asthenia—Vemurafenib—melanoma	0.0012	0.00203	CcSEcCtD
Nelarabine—Hypoaesthesia—Temozolomide—melanoma	0.0012	0.00202	CcSEcCtD
Nelarabine—Chills—Dactinomycin—melanoma	0.0012	0.00202	CcSEcCtD
Nelarabine—Urinary tract disorder—Temozolomide—melanoma	0.00119	0.00201	CcSEcCtD
Nelarabine—Oedema peripheral—Temozolomide—melanoma	0.00119	0.002	CcSEcCtD
Nelarabine—Connective tissue disorder—Temozolomide—melanoma	0.00118	0.002	CcSEcCtD
Nelarabine—Lethargy—Docetaxel—melanoma	0.00118	0.00199	CcSEcCtD
Nelarabine—Urethral disorder—Temozolomide—melanoma	0.00118	0.00199	CcSEcCtD
Nelarabine—Eye disorder—Carmustine—melanoma	0.00117	0.00196	CcSEcCtD
Nelarabine—Pain in extremity—Docetaxel—melanoma	0.00116	0.00195	CcSEcCtD
Nelarabine—Anaemia—Bleomycin—melanoma	0.00115	0.00194	CcSEcCtD
Nelarabine—Diarrhoea—Vemurafenib—melanoma	0.00115	0.00193	CcSEcCtD
Nelarabine—Eye disorder—Temozolomide—melanoma	0.00113	0.0019	CcSEcCtD
Nelarabine—Cardiac disorder—Temozolomide—melanoma	0.00112	0.00189	CcSEcCtD
Nelarabine—Leukopenia—Bleomycin—melanoma	0.00111	0.00188	CcSEcCtD
Nelarabine—Dizziness—Vemurafenib—melanoma	0.00111	0.00187	CcSEcCtD
Nelarabine—Angiopathy—Temozolomide—melanoma	0.00109	0.00184	CcSEcCtD
Nelarabine—Mental disorder—Carmustine—melanoma	0.00109	0.00184	CcSEcCtD
Nelarabine—Ataxia—Docetaxel—melanoma	0.00109	0.00184	CcSEcCtD
Nelarabine—Mediastinal disorder—Temozolomide—melanoma	0.00109	0.00183	CcSEcCtD
Nelarabine—Malnutrition—Carmustine—melanoma	0.00109	0.00183	CcSEcCtD
Nelarabine—Cough—Bleomycin—melanoma	0.00109	0.00183	CcSEcCtD
Nelarabine—Chills—Temozolomide—melanoma	0.00108	0.00182	CcSEcCtD
Nelarabine—Dehydration—Docetaxel—melanoma	0.00108	0.00182	CcSEcCtD
Nelarabine—Anaemia—Dactinomycin—melanoma	0.00107	0.00181	CcSEcCtD
Nelarabine—Vomiting—Vemurafenib—melanoma	0.00107	0.0018	CcSEcCtD
Nelarabine—Chest pain—Bleomycin—melanoma	0.00106	0.00179	CcSEcCtD
Nelarabine—Myalgia—Bleomycin—melanoma	0.00106	0.00179	CcSEcCtD
Nelarabine—Mental disorder—Temozolomide—melanoma	0.00106	0.00178	CcSEcCtD
Nelarabine—Back pain—Carmustine—melanoma	0.00105	0.00177	CcSEcCtD
Nelarabine—Headache—Vemurafenib—melanoma	0.00105	0.00177	CcSEcCtD
Nelarabine—Malnutrition—Temozolomide—melanoma	0.00105	0.00177	CcSEcCtD
Nelarabine—Aspartate aminotransferase increased—Docetaxel—melanoma	0.00104	0.00176	CcSEcCtD
Nelarabine—Leukopenia—Dactinomycin—melanoma	0.00104	0.00175	CcSEcCtD
Nelarabine—Dysgeusia—Temozolomide—melanoma	0.00103	0.00173	CcSEcCtD
Nelarabine—Confusional state—Bleomycin—melanoma	0.00102	0.00173	CcSEcCtD
Nelarabine—Vision blurred—Carmustine—melanoma	0.00102	0.00172	CcSEcCtD
Nelarabine—Tremor—Carmustine—melanoma	0.00102	0.00171	CcSEcCtD
Nelarabine—Oedema—Bleomycin—melanoma	0.00102	0.00171	CcSEcCtD
Nelarabine—Back pain—Temozolomide—melanoma	0.00102	0.00171	CcSEcCtD
Nelarabine—Infection—Bleomycin—melanoma	0.00101	0.0017	CcSEcCtD
Nelarabine—Anaemia—Carmustine—melanoma	0.001	0.00169	CcSEcCtD
Nelarabine—Nausea—Vemurafenib—melanoma	0.000995	0.00168	CcSEcCtD
Nelarabine—Thrombocytopenia—Bleomycin—melanoma	0.000994	0.00168	CcSEcCtD
Nelarabine—Vision blurred—Temozolomide—melanoma	0.000989	0.00167	CcSEcCtD
Nelarabine—Myalgia—Dactinomycin—melanoma	0.000988	0.00166	CcSEcCtD
Nelarabine—Tremor—Temozolomide—melanoma	0.000983	0.00166	CcSEcCtD
Nelarabine—Leukopenia—Carmustine—melanoma	0.000972	0.00164	CcSEcCtD
Nelarabine—Anaemia—Temozolomide—melanoma	0.00097	0.00163	CcSEcCtD
Nelarabine—Anorexia—Bleomycin—melanoma	0.000968	0.00163	CcSEcCtD
Nelarabine—Hypotension—Bleomycin—melanoma	0.000949	0.0016	CcSEcCtD
Nelarabine—Oedema—Dactinomycin—melanoma	0.000947	0.0016	CcSEcCtD
Nelarabine—Convulsion—Carmustine—melanoma	0.000941	0.00159	CcSEcCtD
Nelarabine—Infection—Dactinomycin—melanoma	0.000941	0.00159	CcSEcCtD
Nelarabine—Leukopenia—Temozolomide—melanoma	0.000939	0.00158	CcSEcCtD
Nelarabine—Neutropenia—Docetaxel—melanoma	0.000937	0.00158	CcSEcCtD
Nelarabine—Thrombocytopenia—Dactinomycin—melanoma	0.000927	0.00156	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Bleomycin—melanoma	0.000925	0.00156	CcSEcCtD
Nelarabine—Myalgia—Carmustine—melanoma	0.000925	0.00156	CcSEcCtD
Nelarabine—Chest pain—Carmustine—melanoma	0.000925	0.00156	CcSEcCtD
Nelarabine—Cough—Temozolomide—melanoma	0.000916	0.00154	CcSEcCtD
Nelarabine—Paraesthesia—Bleomycin—melanoma	0.000912	0.00154	CcSEcCtD
Nelarabine—Convulsion—Temozolomide—melanoma	0.000909	0.00153	CcSEcCtD
Nelarabine—Dyspnoea—Bleomycin—melanoma	0.000905	0.00153	CcSEcCtD
Nelarabine—Anorexia—Dactinomycin—melanoma	0.000903	0.00152	CcSEcCtD
Nelarabine—Pneumonia—Docetaxel—melanoma	0.000898	0.00151	CcSEcCtD
Nelarabine—Confusional state—Carmustine—melanoma	0.000894	0.00151	CcSEcCtD
Nelarabine—Arthralgia—Temozolomide—melanoma	0.000893	0.00151	CcSEcCtD
Nelarabine—Myalgia—Temozolomide—melanoma	0.000893	0.00151	CcSEcCtD
Nelarabine—Infestation NOS—Docetaxel—melanoma	0.000893	0.00151	CcSEcCtD
Nelarabine—Infestation—Docetaxel—melanoma	0.000893	0.00151	CcSEcCtD
Nelarabine—Oedema—Carmustine—melanoma	0.000886	0.00149	CcSEcCtD
Nelarabine—Decreased appetite—Bleomycin—melanoma	0.000883	0.00149	CcSEcCtD
Nelarabine—Infection—Carmustine—melanoma	0.00088	0.00148	CcSEcCtD
Nelarabine—Neuropathy peripheral—Docetaxel—melanoma	0.000875	0.00148	CcSEcCtD
Nelarabine—Stomatitis—Docetaxel—melanoma	0.00087	0.00147	CcSEcCtD
Nelarabine—Pain—Bleomycin—melanoma	0.000868	0.00146	CcSEcCtD
Nelarabine—Thrombocytopenia—Carmustine—melanoma	0.000868	0.00146	CcSEcCtD
Nelarabine—Confusional state—Temozolomide—melanoma	0.000864	0.00146	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000863	0.00145	CcSEcCtD
Nelarabine—Oedema—Temozolomide—melanoma	0.000856	0.00144	CcSEcCtD
Nelarabine—Infection—Temozolomide—melanoma	0.000851	0.00143	CcSEcCtD
Nelarabine—Anorexia—Carmustine—melanoma	0.000845	0.00142	CcSEcCtD
Nelarabine—Hepatobiliary disease—Docetaxel—melanoma	0.000845	0.00142	CcSEcCtD
Nelarabine—Epistaxis—Docetaxel—melanoma	0.000842	0.00142	CcSEcCtD
Nelarabine—Nervous system disorder—Temozolomide—melanoma	0.00084	0.00142	CcSEcCtD
Nelarabine—Thrombocytopenia—Temozolomide—melanoma	0.000839	0.00141	CcSEcCtD
Nelarabine—Feeling abnormal—Bleomycin—melanoma	0.000837	0.00141	CcSEcCtD
Nelarabine—Hypotension—Carmustine—melanoma	0.000828	0.0014	CcSEcCtD
Nelarabine—Decreased appetite—Dactinomycin—melanoma	0.000823	0.00139	CcSEcCtD
Nelarabine—Fatigue—Dactinomycin—melanoma	0.000816	0.00138	CcSEcCtD
Nelarabine—Anorexia—Temozolomide—melanoma	0.000816	0.00138	CcSEcCtD
Nelarabine—Pain—Dactinomycin—melanoma	0.00081	0.00136	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Carmustine—melanoma	0.000807	0.00136	CcSEcCtD
Nelarabine—Body temperature increased—Bleomycin—melanoma	0.000803	0.00135	CcSEcCtD
Nelarabine—Insomnia—Carmustine—melanoma	0.000802	0.00135	CcSEcCtD
Nelarabine—Hypoaesthesia—Docetaxel—melanoma	0.000798	0.00134	CcSEcCtD
Nelarabine—Paraesthesia—Carmustine—melanoma	0.000796	0.00134	CcSEcCtD
Nelarabine—Urinary tract disorder—Docetaxel—melanoma	0.000792	0.00133	CcSEcCtD
Nelarabine—Dyspnoea—Carmustine—melanoma	0.00079	0.00133	CcSEcCtD
Nelarabine—Oedema peripheral—Docetaxel—melanoma	0.00079	0.00133	CcSEcCtD
Nelarabine—Somnolence—Carmustine—melanoma	0.000788	0.00133	CcSEcCtD
Nelarabine—Connective tissue disorder—Docetaxel—melanoma	0.000788	0.00133	CcSEcCtD
Nelarabine—Urethral disorder—Docetaxel—melanoma	0.000786	0.00132	CcSEcCtD
Nelarabine—Feeling abnormal—Dactinomycin—melanoma	0.00078	0.00132	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Temozolomide—melanoma	0.00078	0.00132	CcSEcCtD
Nelarabine—Insomnia—Temozolomide—melanoma	0.000775	0.00131	CcSEcCtD
Nelarabine—Gastrointestinal pain—Dactinomycin—melanoma	0.000774	0.00131	CcSEcCtD
Nelarabine—DCK—Retinoblastoma (RB) in Cancer—MDM2—melanoma	0.000773	0.00247	CbGpPWpGaD
Nelarabine—Decreased appetite—Carmustine—melanoma	0.00077	0.0013	CcSEcCtD
Nelarabine—Paraesthesia—Temozolomide—melanoma	0.000769	0.0013	CcSEcCtD
Nelarabine—POLA1—DNA Replication—PCNA—melanoma	0.000766	0.00245	CbGpPWpGaD
Nelarabine—Gastrointestinal disorder—Carmustine—melanoma	0.000765	0.00129	CcSEcCtD
Nelarabine—POLA1—E2F transcription factor network—RB1—melanoma	0.000764	0.00244	CbGpPWpGaD
Nelarabine—Dyspnoea—Temozolomide—melanoma	0.000764	0.00129	CcSEcCtD
Nelarabine—POLA1—Retinoblastoma (RB) in Cancer—CDK4—melanoma	0.000763	0.00244	CbGpPWpGaD
Nelarabine—ADA—p73 transcription factor network—CDKN1A—melanoma	0.000763	0.00244	CbGpPWpGaD
Nelarabine—Somnolence—Temozolomide—melanoma	0.000761	0.00128	CcSEcCtD
Nelarabine—POLA1—Cell Cycle, Mitotic—INCENP—melanoma	0.00076	0.00243	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—PKMYT1—melanoma	0.00076	0.00243	CbGpPWpGaD
Nelarabine—Constipation—Carmustine—melanoma	0.000758	0.00128	CcSEcCtD
Nelarabine—Pain—Carmustine—melanoma	0.000758	0.00128	CcSEcCtD
Nelarabine—DGUOK—Metabolism—VCAN—melanoma	0.000754	0.00241	CbGpPWpGaD
Nelarabine—ADA—C-MYB transcription factor network—CCND1—melanoma	0.000751	0.0024	CbGpPWpGaD
Nelarabine—Eye disorder—Docetaxel—melanoma	0.000749	0.00126	CcSEcCtD
Nelarabine—Abdominal pain—Dactinomycin—melanoma	0.000749	0.00126	CcSEcCtD
Nelarabine—Body temperature increased—Dactinomycin—melanoma	0.000749	0.00126	CcSEcCtD
Nelarabine—POLA1—Synthesis of DNA—CDK2—melanoma	0.000747	0.00239	CbGpPWpGaD
Nelarabine—Decreased appetite—Temozolomide—melanoma	0.000745	0.00125	CcSEcCtD
Nelarabine—Cardiac disorder—Docetaxel—melanoma	0.000744	0.00125	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Temozolomide—melanoma	0.000739	0.00125	CcSEcCtD
Nelarabine—Fatigue—Temozolomide—melanoma	0.000738	0.00124	CcSEcCtD
Nelarabine—POLA1—G1/S Transition—PCNA—melanoma	0.000737	0.00236	CbGpPWpGaD
Nelarabine—Constipation—Temozolomide—melanoma	0.000732	0.00123	CcSEcCtD
Nelarabine—Pain—Temozolomide—melanoma	0.000732	0.00123	CcSEcCtD
Nelarabine—Feeling abnormal—Carmustine—melanoma	0.00073	0.00123	CcSEcCtD
Nelarabine—Asthenia—Bleomycin—melanoma	0.000728	0.00123	CcSEcCtD
Nelarabine—Angiopathy—Docetaxel—melanoma	0.000727	0.00123	CcSEcCtD
Nelarabine—ADA—C-MYB transcription factor network—CDKN1A—melanoma	0.000726	0.00232	CbGpPWpGaD
Nelarabine—Gastrointestinal pain—Carmustine—melanoma	0.000725	0.00122	CcSEcCtD
Nelarabine—Mediastinal disorder—Docetaxel—melanoma	0.000723	0.00122	CcSEcCtD
Nelarabine—Chills—Docetaxel—melanoma	0.000719	0.00121	CcSEcCtD
Nelarabine—POLA1—Mitotic G1-G1/S phases—CDKN2B—melanoma	0.000718	0.00229	CbGpPWpGaD
Nelarabine—DCK—Retinoblastoma (RB) in Cancer—CDKN1B—melanoma	0.000706	0.00226	CbGpPWpGaD
Nelarabine—Feeling abnormal—Temozolomide—melanoma	0.000706	0.00119	CcSEcCtD
Nelarabine—Mental disorder—Docetaxel—melanoma	0.000702	0.00118	CcSEcCtD
Nelarabine—Body temperature increased—Carmustine—melanoma	0.000701	0.00118	CcSEcCtD
Nelarabine—Abdominal pain—Carmustine—melanoma	0.000701	0.00118	CcSEcCtD
Nelarabine—Gastrointestinal pain—Temozolomide—melanoma	0.0007	0.00118	CcSEcCtD
Nelarabine—POLA1—DNA Replication—CDK2—melanoma	0.0007	0.00224	CbGpPWpGaD
Nelarabine—Malnutrition—Docetaxel—melanoma	0.000698	0.00118	CcSEcCtD
Nelarabine—ADA—Metabolism—ACER3—melanoma	0.000693	0.00221	CbGpPWpGaD
Nelarabine—Dysgeusia—Docetaxel—melanoma	0.000683	0.00115	CcSEcCtD
Nelarabine—POLA1—Cell Cycle—INCENP—melanoma	0.00068	0.00217	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—PKMYT1—melanoma	0.00068	0.00217	CbGpPWpGaD
Nelarabine—Asthenia—Dactinomycin—melanoma	0.000679	0.00115	CcSEcCtD
Nelarabine—Body temperature increased—Temozolomide—melanoma	0.000677	0.00114	CcSEcCtD
Nelarabine—Abdominal pain—Temozolomide—melanoma	0.000677	0.00114	CcSEcCtD
Nelarabine—Back pain—Docetaxel—melanoma	0.000675	0.00114	CcSEcCtD
Nelarabine—POLA1—G1/S Transition—CDK2—melanoma	0.000674	0.00216	CbGpPWpGaD
Nelarabine—DCK—Retinoblastoma (RB) in Cancer—CCND1—melanoma	0.000674	0.00215	CbGpPWpGaD
Nelarabine—POLA1—E2F transcription factor network—CDKN2A—melanoma	0.000671	0.00215	CbGpPWpGaD
Nelarabine—POLA1—S Phase—PCNA—melanoma	0.00067	0.00214	CbGpPWpGaD
Nelarabine—POLA1—Retinoblastoma (RB) in Cancer—RB1—melanoma	0.000664	0.00212	CbGpPWpGaD
Nelarabine—POLA1—Mitotic G1-G1/S phases—E2F1—melanoma	0.000659	0.00211	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—FAS—melanoma	0.000657	0.0021	CbGpPWpGaD
Nelarabine—DCK—Retinoblastoma (RB) in Cancer—CDKN1A—melanoma	0.000652	0.00208	CbGpPWpGaD
Nelarabine—Diarrhoea—Dactinomycin—melanoma	0.000648	0.00109	CcSEcCtD
Nelarabine—ADA—C-MYB transcription factor network—NRAS—melanoma	0.000646	0.00207	CbGpPWpGaD
Nelarabine—Vomiting—Bleomycin—melanoma	0.000646	0.00109	CcSEcCtD
Nelarabine—Anaemia—Docetaxel—melanoma	0.000645	0.00109	CcSEcCtD
Nelarabine—DCK—Metabolism—ACER3—melanoma	0.000639	0.00204	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—CYP17A1—melanoma	0.000636	0.00203	CbGpPWpGaD
Nelarabine—Asthenia—Carmustine—melanoma	0.000636	0.00107	CcSEcCtD
Nelarabine—ADA—Metabolism—UGT2B10—melanoma	0.000633	0.00202	CbGpPWpGaD
Nelarabine—ADA—p73 transcription factor network—MYC—melanoma	0.000632	0.00202	CbGpPWpGaD
Nelarabine—Leukopenia—Docetaxel—melanoma	0.000625	0.00105	CcSEcCtD
Nelarabine—POLA1—Mitotic G1-G1/S phases—PCNA—melanoma	0.000621	0.00199	CbGpPWpGaD
Nelarabine—Asthenia—Temozolomide—melanoma	0.000614	0.00104	CcSEcCtD
Nelarabine—POLA1—Synthesis of DNA—RB1—melanoma	0.000614	0.00196	CbGpPWpGaD
Nelarabine—Loss of consciousness—Docetaxel—melanoma	0.000613	0.00103	CcSEcCtD
Nelarabine—POLA1—S Phase—CDK2—melanoma	0.000612	0.00196	CbGpPWpGaD
Nelarabine—Cough—Docetaxel—melanoma	0.000609	0.00103	CcSEcCtD
Nelarabine—Diarrhoea—Carmustine—melanoma	0.000606	0.00102	CcSEcCtD
Nelarabine—Convulsion—Docetaxel—melanoma	0.000605	0.00102	CcSEcCtD
Nelarabine—Nausea—Bleomycin—melanoma	0.000603	0.00102	CcSEcCtD
Nelarabine—ADA—C-MYB transcription factor network—MYC—melanoma	0.000602	0.00192	CbGpPWpGaD
Nelarabine—Vomiting—Dactinomycin—melanoma	0.000602	0.00101	CcSEcCtD
Nelarabine—DGUOK—Metabolism—GNA11—melanoma	0.000601	0.00192	CbGpPWpGaD
Nelarabine—POLA1—E2F transcription factor network—CDKN1B—melanoma	0.000595	0.0019	CbGpPWpGaD
Nelarabine—Arthralgia—Docetaxel—melanoma	0.000594	0.001	CcSEcCtD
Nelarabine—Myalgia—Docetaxel—melanoma	0.000594	0.001	CcSEcCtD
Nelarabine—Chest pain—Docetaxel—melanoma	0.000594	0.001	CcSEcCtD
Nelarabine—ADA—Metabolism—HS3ST5—melanoma	0.000589	0.00188	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—FASN—melanoma	0.000588	0.00188	CbGpPWpGaD
Nelarabine—Dizziness—Carmustine—melanoma	0.000586	0.000988	CcSEcCtD
Nelarabine—Diarrhoea—Temozolomide—melanoma	0.000586	0.000988	CcSEcCtD
Nelarabine—DCK—Metabolism—UGT2B10—melanoma	0.000585	0.00187	CbGpPWpGaD
Nelarabine—POLA1—S Phase—CDK4—melanoma	0.000579	0.00185	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—CDK4—melanoma	0.000578	0.00185	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—SLC5A5—melanoma	0.000578	0.00185	CbGpPWpGaD
Nelarabine—POLA1—DNA Replication—RB1—melanoma	0.000576	0.00184	CbGpPWpGaD
Nelarabine—Confusional state—Docetaxel—melanoma	0.000574	0.000968	CcSEcCtD
Nelarabine—POLA1—Cell Cycle—POT1—melanoma	0.000572	0.00183	CbGpPWpGaD
Nelarabine—Oedema—Docetaxel—melanoma	0.00057	0.00096	CcSEcCtD
Nelarabine—POLA1—Mitotic G1-G1/S phases—CDK2—melanoma	0.000568	0.00182	CbGpPWpGaD
Nelarabine—Dizziness—Temozolomide—melanoma	0.000566	0.000955	CcSEcCtD
Nelarabine—POLA1—Retinoblastoma (RB) in Cancer—MDM2—melanoma	0.000566	0.00181	CbGpPWpGaD
Nelarabine—Infection—Docetaxel—melanoma	0.000566	0.000954	CcSEcCtD
Nelarabine—Vomiting—Carmustine—melanoma	0.000563	0.00095	CcSEcCtD
Nelarabine—Nausea—Dactinomycin—melanoma	0.000562	0.000948	CcSEcCtD
Nelarabine—ADA—Circadian rythm related genes—NOS2—melanoma	0.000562	0.0018	CbGpPWpGaD
Nelarabine—Nervous system disorder—Docetaxel—melanoma	0.000559	0.000941	CcSEcCtD
Nelarabine—DGUOK—Metabolism—GNAQ—melanoma	0.000558	0.00178	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—CD44—melanoma	0.000558	0.00178	CbGpPWpGaD
Nelarabine—Thrombocytopenia—Docetaxel—melanoma	0.000558	0.00094	CcSEcCtD
Nelarabine—ADA—C-MYB transcription factor network—KRAS—melanoma	0.000556	0.00178	CbGpPWpGaD
Nelarabine—Headache—Carmustine—melanoma	0.000555	0.000936	CcSEcCtD
Nelarabine—POLA1—G1/S Transition—RB1—melanoma	0.000554	0.00177	CbGpPWpGaD
Nelarabine—POLA1—E2F transcription factor network—CDKN1A—melanoma	0.000549	0.00175	CbGpPWpGaD
Nelarabine—Vomiting—Temozolomide—melanoma	0.000545	0.000918	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN2B—melanoma	0.000544	0.00174	CbGpPWpGaD
Nelarabine—DCK—Metabolism—HS3ST5—melanoma	0.000544	0.00174	CbGpPWpGaD
Nelarabine—Anorexia—Docetaxel—melanoma	0.000543	0.000915	CcSEcCtD
Nelarabine—DCK—Retinoblastoma (RB) in Cancer—MYC—melanoma	0.00054	0.00173	CbGpPWpGaD
Nelarabine—POLA1—Mitotic G1-G1/S phases—CDK4—melanoma	0.000537	0.00172	CbGpPWpGaD
Nelarabine—Headache—Temozolomide—melanoma	0.000537	0.000904	CcSEcCtD
Nelarabine—DGUOK—Metabolism—CYP1B1—melanoma	0.000535	0.00171	CbGpPWpGaD
Nelarabine—Hypotension—Docetaxel—melanoma	0.000532	0.000897	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—ABCB1—melanoma	0.000531	0.0017	CbGpPWpGaD
Nelarabine—Nausea—Carmustine—melanoma	0.000526	0.000887	CcSEcCtD
Nelarabine—ADA—Circadian rythm related genes—PPARG—melanoma	0.000526	0.00168	CbGpPWpGaD
Nelarabine—Musculoskeletal discomfort—Docetaxel—melanoma	0.000519	0.000875	CcSEcCtD
Nelarabine—POLA1—Retinoblastoma (RB) in Cancer—CDKN1B—melanoma	0.000517	0.00165	CbGpPWpGaD
Nelarabine—Insomnia—Docetaxel—melanoma	0.000515	0.000868	CcSEcCtD
Nelarabine—Paraesthesia—Docetaxel—melanoma	0.000511	0.000862	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—FGF1—melanoma	0.00051	0.00163	CbGpPWpGaD
Nelarabine—Nausea—Temozolomide—melanoma	0.000509	0.000857	CcSEcCtD
Nelarabine—Dyspnoea—Docetaxel—melanoma	0.000508	0.000856	CcSEcCtD
Nelarabine—Somnolence—Docetaxel—melanoma	0.000506	0.000853	CcSEcCtD
Nelarabine—POLA1—S Phase—RB1—melanoma	0.000503	0.00161	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—E2F1—melanoma	0.000499	0.0016	CbGpPWpGaD
Nelarabine—Decreased appetite—Docetaxel—melanoma	0.000495	0.000835	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—PDGFRA—melanoma	0.000494	0.00158	CbGpPWpGaD
Nelarabine—POLA1—Retinoblastoma (RB) in Cancer—CCND1—melanoma	0.000493	0.00158	CbGpPWpGaD
Nelarabine—Gastrointestinal disorder—Docetaxel—melanoma	0.000492	0.000829	CcSEcCtD
Nelarabine—Fatigue—Docetaxel—melanoma	0.000491	0.000828	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—PRKCA—melanoma	0.000489	0.00156	CbGpPWpGaD
Nelarabine—Pain—Docetaxel—melanoma	0.000487	0.000821	CcSEcCtD
Nelarabine—Constipation—Docetaxel—melanoma	0.000487	0.000821	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—FASLG—melanoma	0.00048	0.00153	CbGpPWpGaD
Nelarabine—POLA1—Synthesis of DNA—CDKN1B—melanoma	0.000478	0.00153	CbGpPWpGaD
Nelarabine—POLA1—Retinoblastoma (RB) in Cancer—CDKN1A—melanoma	0.000477	0.00152	CbGpPWpGaD
Nelarabine—ADA—C-MYB transcription factor network—HRAS—melanoma	0.000473	0.00151	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—PCNA—melanoma	0.000471	0.0015	CbGpPWpGaD
Nelarabine—Feeling abnormal—Docetaxel—melanoma	0.000469	0.000791	CcSEcCtD
Nelarabine—POLA1—Mitotic G1-G1/S phases—RB1—melanoma	0.000467	0.00149	CbGpPWpGaD
Nelarabine—Gastrointestinal pain—Docetaxel—melanoma	0.000466	0.000785	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—FAS—melanoma	0.000463	0.00148	CbGpPWpGaD
Nelarabine—POLA1—E2F transcription factor network—MYC—melanoma	0.000455	0.00145	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—RAC1—melanoma	0.000453	0.00145	CbGpPWpGaD
Nelarabine—Abdominal pain—Docetaxel—melanoma	0.00045	0.000759	CcSEcCtD
Nelarabine—Body temperature increased—Docetaxel—melanoma	0.00045	0.000759	CcSEcCtD
Nelarabine—POLA1—DNA Replication—CDKN1B—melanoma	0.000448	0.00143	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PLCB4—melanoma	0.000446	0.00143	CbGpPWpGaD
Nelarabine—DCK—Retinoblastoma (RB) in Cancer—TP53—melanoma	0.000444	0.00142	CbGpPWpGaD
Nelarabine—POLA1—Synthesis of DNA—CDKN1A—melanoma	0.000441	0.00141	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—ABCB1—melanoma	0.000441	0.00141	CbGpPWpGaD
Nelarabine—POLA1—G1/S Transition—CDKN1B—melanoma	0.000432	0.00138	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDK2—melanoma	0.000431	0.00138	CbGpPWpGaD
Nelarabine—ADA—Metabolism—SLC6A11—melanoma	0.00042	0.00134	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PIP4K2A—melanoma	0.00042	0.00134	CbGpPWpGaD
Nelarabine—POLA1—DNA Replication—CDKN1A—melanoma	0.000413	0.00132	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PLCB4—melanoma	0.000412	0.00132	CbGpPWpGaD
Nelarabine—POLA1—Mitotic G1-G1/S phases—CDKN2A—melanoma	0.000411	0.00131	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—ATM—melanoma	0.000409	0.00131	CbGpPWpGaD
Nelarabine—Asthenia—Docetaxel—melanoma	0.000409	0.000689	CcSEcCtD
Nelarabine—ADA—Metabolism—MTAP—melanoma	0.000408	0.0013	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDK4—melanoma	0.000407	0.0013	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—PRKCA—melanoma	0.000406	0.0013	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—ERCC2—melanoma	0.000402	0.00129	CbGpPWpGaD
Nelarabine—POLA1—G1/S Transition—CDKN1A—melanoma	0.000398	0.00127	CbGpPWpGaD
Nelarabine—POLA1—Retinoblastoma (RB) in Cancer—MYC—melanoma	0.000395	0.00126	CbGpPWpGaD
Nelarabine—POLA1—S Phase—CDKN1B—melanoma	0.000392	0.00125	CbGpPWpGaD
Nelarabine—Diarrhoea—Docetaxel—melanoma	0.00039	0.000657	CcSEcCtD
Nelarabine—DCK—Metabolism—SLC6A11—melanoma	0.000387	0.00124	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PIP4K2A—melanoma	0.000387	0.00124	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—SKP2—melanoma	0.000383	0.00122	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—APC—melanoma	0.000383	0.00122	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—EGF—melanoma	0.000379	0.00121	CbGpPWpGaD
Nelarabine—DCK—Metabolism—MTAP—melanoma	0.000377	0.0012	CbGpPWpGaD
Nelarabine—Dizziness—Docetaxel—melanoma	0.000377	0.000635	CcSEcCtD
Nelarabine—POLA1—S Phase—CCND1—melanoma	0.000374	0.00119	CbGpPWpGaD
Nelarabine—Adenosine triphosphate—ABCB1—melanoma	0.000365	0.036	CrCbGaD
Nelarabine—ADA—Metabolism—PHGDH—melanoma	0.000364	0.00116	CbGpPWpGaD
Nelarabine—ADA—Metabolism—LUM—melanoma	0.000364	0.00116	CbGpPWpGaD
Nelarabine—POLA1—Mitotic G1-G1/S phases—CDKN1B—melanoma	0.000364	0.00116	CbGpPWpGaD
Nelarabine—Vomiting—Docetaxel—melanoma	0.000362	0.00061	CcSEcCtD
Nelarabine—POLA1—S Phase—CDKN1A—melanoma	0.000362	0.00116	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—PTEN—melanoma	0.000361	0.00115	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—CASP8—melanoma	0.000357	0.00114	CbGpPWpGaD
Nelarabine—Headache—Docetaxel—melanoma	0.000357	0.000601	CcSEcCtD
Nelarabine—ADA—Metabolism—HPSE—melanoma	0.000357	0.00114	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—IGF1—melanoma	0.000351	0.00112	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—AURKA—melanoma	0.000351	0.00112	CbGpPWpGaD
Nelarabine—ADA—Metabolism—CUBN—melanoma	0.00035	0.00112	CbGpPWpGaD
Nelarabine—POLA1—Mitotic G1-G1/S phases—CCND1—melanoma	0.000347	0.00111	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—MLH1—melanoma	0.000347	0.00111	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—SKP2—melanoma	0.000343	0.00109	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—MAP2K1—melanoma	0.000339	0.00108	CbGpPWpGaD
Nelarabine—Nausea—Docetaxel—melanoma	0.000338	0.00057	CcSEcCtD
Nelarabine—ADA—Metabolism—SDHD—melanoma	0.000338	0.00108	CbGpPWpGaD
Nelarabine—ADA—Metabolism—BSG—melanoma	0.000338	0.00108	CbGpPWpGaD
Nelarabine—ADA—Metabolism—CSPG4—melanoma	0.000338	0.00108	CbGpPWpGaD
Nelarabine—DCK—Metabolism—LUM—melanoma	0.000336	0.00107	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PHGDH—melanoma	0.000336	0.00107	CbGpPWpGaD
Nelarabine—POLA1—Mitotic G1-G1/S phases—CDKN1A—melanoma	0.000336	0.00107	CbGpPWpGaD
Nelarabine—POLA1—G1/S Transition—MYC—melanoma	0.00033	0.00106	CbGpPWpGaD
Nelarabine—DCK—Metabolism—HPSE—melanoma	0.000329	0.00105	CbGpPWpGaD
Nelarabine—ADA—Metabolism—GPAM—melanoma	0.000328	0.00105	CbGpPWpGaD
Nelarabine—POLA1—Retinoblastoma (RB) in Cancer—TP53—melanoma	0.000325	0.00104	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CUBN—melanoma	0.000323	0.00103	CbGpPWpGaD
Nelarabine—POLA1—Mitotic M-M/G1 phases—E2F1—melanoma	0.000323	0.00103	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—FGF2—melanoma	0.000322	0.00103	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—PIK3CG—melanoma	0.000318	0.00102	CbGpPWpGaD
Nelarabine—POLA1—Mitotic M-M/G1 phases—PRKCA—melanoma	0.000317	0.00101	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—AURKA—melanoma	0.000313	0.001	CbGpPWpGaD
Nelarabine—DCK—Metabolism—SDHD—melanoma	0.000312	0.000997	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CSPG4—melanoma	0.000312	0.000997	CbGpPWpGaD
Nelarabine—DCK—Metabolism—BSG—melanoma	0.000312	0.000997	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—PPARG—melanoma	0.000307	0.00098	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—BCL2—melanoma	0.000306	0.000978	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—APEX1—melanoma	0.000304	0.000973	CbGpPWpGaD
Nelarabine—DCK—Metabolism—GPAM—melanoma	0.000302	0.000966	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—MDM2—melanoma	0.000302	0.000964	CbGpPWpGaD
Nelarabine—POLA1—S Phase—MYC—melanoma	0.0003	0.000958	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—ERBB2—melanoma	0.000297	0.00095	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—PTGS2—melanoma	0.000291	0.000929	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—PIK3CD—melanoma	0.000279	0.000892	CbGpPWpGaD
Nelarabine—POLA1—Mitotic M-M/G1 phases—CDK2—melanoma	0.000279	0.000891	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PLA2G6—melanoma	0.000279	0.00089	CbGpPWpGaD
Nelarabine—POLA1—Mitotic G1-G1/S phases—MYC—melanoma	0.000278	0.000889	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—ALB—melanoma	0.000276	0.000881	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	0.000275	0.00088	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—APEX1—melanoma	0.000272	0.00087	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	0.00027	0.000863	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—CDKN2B—melanoma	0.000263	0.000841	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	0.000263	0.00084	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	0.00026	0.000832	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PLA2G6—melanoma	0.000257	0.000821	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	0.000254	0.000812	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	0.000254	0.000811	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	0.000252	0.000807	CbGpPWpGaD
Nelarabine—ADA—Metabolism—VCAN—melanoma	0.00025	0.000799	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—TP53—melanoma	0.000246	0.000786	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—PIK3CB—melanoma	0.000243	0.000778	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—E2F1—melanoma	0.000242	0.000772	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—PTGS2—melanoma	0.000241	0.000771	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—PRKCA—melanoma	0.000237	0.000757	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—CDKN2B—melanoma	0.000235	0.000752	CbGpPWpGaD
Nelarabine—DCK—Metabolism—VCAN—melanoma	0.000231	0.000738	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	0.000229	0.000732	CbGpPWpGaD
Nelarabine—POLA1—Mitotic M-M/G1 phases—RB1—melanoma	0.000229	0.000732	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—PCNA—melanoma	0.000228	0.000728	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—IL6—melanoma	0.000225	0.00072	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	0.000217	0.000693	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—E2F1—melanoma	0.000216	0.00069	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—PRKCA—melanoma	0.000212	0.000676	CbGpPWpGaD
Nelarabine—ADA—Metabolism—CYP17A1—melanoma	0.000211	0.000674	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—MYC—melanoma	0.000211	0.000674	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—PTEN—melanoma	0.00021	0.000672	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—CDK2—melanoma	0.000208	0.000666	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	0.000206	0.000659	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	0.000206	0.000659	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—PCNA—melanoma	0.000204	0.000651	CbGpPWpGaD
Nelarabine—ADA—Metabolism—GNA11—melanoma	0.000199	0.000637	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—CDK4—melanoma	0.000197	0.00063	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—TERT—melanoma	0.000197	0.000629	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—TNF—melanoma	0.000196	0.000627	CbGpPWpGaD
Nelarabine—ADA—Metabolism—FASN—melanoma	0.000195	0.000623	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CYP17A1—melanoma	0.000195	0.000622	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	0.000195	0.000622	CbGpPWpGaD
Nelarabine—ADA—Metabolism—SLC5A5—melanoma	0.000192	0.000613	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—CDK2—melanoma	0.000186	0.000596	CbGpPWpGaD
Nelarabine—ADA—Metabolism—GNAQ—melanoma	0.000185	0.000592	CbGpPWpGaD
Nelarabine—ADA—Metabolism—CD44—melanoma	0.000185	0.000592	CbGpPWpGaD
Nelarabine—DCK—Metabolism—GNA11—melanoma	0.000184	0.000588	CbGpPWpGaD
Nelarabine—DCK—Metabolism—FASN—melanoma	0.00018	0.000575	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	0.000179	0.000572	CbGpPWpGaD
Nelarabine—ADA—Metabolism—CYP1B1—melanoma	0.000178	0.000568	CbGpPWpGaD
Nelarabine—DCK—Metabolism—SLC5A5—melanoma	0.000177	0.000566	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—ATM—melanoma	0.000177	0.000565	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—CDK4—melanoma	0.000176	0.000563	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	0.000173	0.000553	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—RB1—melanoma	0.000171	0.000547	CbGpPWpGaD
Nelarabine—DCK—Metabolism—GNAQ—melanoma	0.000171	0.000546	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CD44—melanoma	0.000171	0.000546	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CYP1B1—melanoma	0.000164	0.000524	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—RB1—melanoma	0.000153	0.000489	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—CDKN2A—melanoma	0.000151	0.000481	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—PIK3CA—melanoma	0.000148	0.000474	CbGpPWpGaD
Nelarabine—ADA—Metabolism—ABCB1—melanoma	0.000146	0.000468	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	0.000146	0.000467	CbGpPWpGaD
Nelarabine—POLA1—Mitotic M-M/G1 phases—MAPK3—melanoma	0.00014	0.000448	CbGpPWpGaD
Nelarabine—DCK—Metabolism—ABCB1—melanoma	0.000135	0.000431	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PRKCA—melanoma	0.000135	0.00043	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—CDKN2A—melanoma	0.000135	0.00043	CbGpPWpGaD
Nelarabine—ADA—Metabolism—ERCC2—melanoma	0.000134	0.000427	CbGpPWpGaD
Nelarabine—POLA1—Mitotic M-M/G1 phases—MAPK1—melanoma	0.000133	0.000426	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—CDKN1B—melanoma	0.000133	0.000426	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—MDM2—melanoma	0.000131	0.000417	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—CCND1—melanoma	0.000127	0.000407	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PRKCA—melanoma	0.000124	0.000397	CbGpPWpGaD
Nelarabine—DCK—Metabolism—ERCC2—melanoma	0.000123	0.000394	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—CDKN1A—melanoma	0.000123	0.000393	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—AKT1—melanoma	0.000121	0.000387	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—CDKN1B—melanoma	0.000119	0.000381	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—CCND1—melanoma	0.000114	0.000363	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—CDKN1A—melanoma	0.00011	0.000352	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PIK3CG—melanoma	0.000105	0.000337	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—MAPK3—melanoma	0.000105	0.000335	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—MYC—melanoma	0.000102	0.000326	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PPARG—melanoma	0.000102	0.000325	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—MAPK1—melanoma	9.98e-05	0.000319	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PIK3CG—melanoma	9.73e-05	0.000311	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PPARG—melanoma	9.39e-05	0.0003	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—MAPK3—melanoma	9.38e-05	0.0003	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PIK3CD—melanoma	9.27e-05	0.000296	CbGpPWpGaD
Nelarabine—ADA—Metabolism—ALB—melanoma	9.15e-05	0.000292	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—MYC—melanoma	9.13e-05	0.000292	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—MAPK1—melanoma	8.93e-05	0.000285	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PIK3CD—melanoma	8.56e-05	0.000273	CbGpPWpGaD
Nelarabine—DCK—Metabolism—ALB—melanoma	8.45e-05	0.00027	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PIK3CB—melanoma	8.08e-05	0.000258	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PTGS2—melanoma	8.01e-05	0.000256	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—TP53—melanoma	7.49e-05	0.000239	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PIK3CB—melanoma	7.46e-05	0.000238	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PTGS2—melanoma	7.39e-05	0.000236	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PTEN—melanoma	6.98e-05	0.000223	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PTEN—melanoma	6.45e-05	0.000206	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PIK3CA—melanoma	4.93e-05	0.000157	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PIK3CA—melanoma	4.55e-05	0.000145	CbGpPWpGaD
Nelarabine—ADA—Metabolism—AKT1—melanoma	4.02e-05	0.000129	CbGpPWpGaD
Nelarabine—DCK—Metabolism—AKT1—melanoma	3.71e-05	0.000119	CbGpPWpGaD
